Sign in

CIK 0001677077

  • Emerging growth company

Alzamend Neuro, Inc.

Sign in to watch
Ticker
ALZN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Apr 30
Incorporated
DE
Entity type
Operating
EIN
811822909
Phone
+1 844-722-6333
Business address
480 PEACHTREE ROAD NE, SECOND FLOOR, SUITE 103, ATLANTA, GA, 30326
  1. 8-K Event Material agreement
  2. 8-K Event Regulation FD disclosure
  3. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure
  4. 8-K Event Shareholder vote results
  5. 8-K Event Regulation FD disclosure
  6. 8-K Event Regulation FD disclosure
  7. 8-K Event Exhibits
  8. 8-K/A Event Material agreement · Unregistered share sale · Bylaws or fiscal year change · Regulation FD disclosure
  9. 8-K Event Material agreement · Regulation FD disclosure
  10. 8-K Event Auditor change
  11. 8-K Event Agreement ended · Regulation FD disclosure
  12. 8-K Event Shareholder vote results
  13. 8-K Event Material agreement · New debt or obligation · Unregistered share sale
  14. 8-K Event Material agreement · Delisting notice · Unregistered share sale
  15. 8-K Event Material agreement · Shareholder rights changed · Bylaws or fiscal year change
  16. 8-K Event Bylaws or fiscal year change
  17. 8-K Event Material agreement · Delisting notice · Unregistered share sale · Bylaws or fiscal year change
  18. 8-K Event Executive or director change
  19. 8-K Event Regulation FD disclosure
  20. 8-K Event Bylaws or fiscal year change · Regulation FD disclosure

Page 2 of 4 · 72 filings